Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients
2008
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Cancer Statistics, 2021
2021 Standout
Osteosarcoma incidence and survival rates from 1973 to 2004
2009 Standout
Inflammation and Alzheimer's disease
2000 Standout
Computed Tomography — An Increasing Source of Radiation Exposure
2007 Standout
A population-based study of the usefulness of screening for neuroblastoma
1996
MYC on the Path to Cancer
2012 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Hepatocellular carcinoma
2018 Standout
Trials of prostate-cancer screening are not worthwhile
2009
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
2007
Computed Tomography Screening and Lung Cancer Outcomes
2007
Heating the patient: a promising approach?
2002 Standout
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high‐risk sarcomas
2006
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
Cancer Metastasis: Building a Framework
2006 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
Update on childhood rhabdomyosarcoma
2003
BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis
2018
Overdiagnosis in Cancer
2010
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Immunoregulators in the nervous system
1991
Common Musculoskeletal Tumors of Childhood and Adolescence
2012
Skin biopsy rates and incidence of melanoma: population based ecological study
2005
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Hepatocellular carcinoma
2012 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Characterization and transcriptional profiles of a Drosophila gene encoding an insect defensin
1994 StandoutNobel
A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma
2008 Standout
COMPARISON OF DOXORUBICIN CARDIOTOXICITY IN PEDIATRIC SARCOMA PATIENTS WHEN GIVEN WITH DEXRAZOXANE VERSUS AS CONTINUOUS INFUSION
2010
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
2005 Standout
Childhood soft tissue sarcomas incidence and survival in European children (1978–1997): Report from the Automated Childhood Cancer Information System project
2006
Targeting apoptosis in cancer therapy
2020 Standout
Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling
2014
Bladder cancer
2016 Standout
Chemotherapy Is Associated With Improved Survival in Adult Patients With Primary Extremity Synovial Sarcoma
2007
Pegylated asparaginase (OncasparTM) in children with ALL: drug monitoring in reinduction according to the ALL/NHL‐BFM 95 protocols
2000
Recent Advances in Neuroblastoma
2010
Principles of Cancer Screening: Lessons From History and Study Design Issues
2010
Mechanisms of Antimicrobial Peptide Action and Resistance
2003 Standout
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
2005
Hyperthermia adds to chemotherapy
2008
Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution
2004
Neuroblastoma
2007 Standout
Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian Cells
1993
Clustering of Gene Hypermethylation Associated With Clinical Risk Groups in Neuroblastoma
2004
Defensins: a family of antimicrobial and cytotoxic peptides
1994
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Androgens and liver tumors: Fanconi's anemia and non‐Fanconi's conditions
2004
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Cancer epigenomics: DNA methylomes and histone-modification maps
2007 Standout
Screening of Infants and Mortality Due to Neuroblastoma
2002
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
2002 Standout
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
2015
Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005
2009
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Congenital alveolar rhabdomyosarcomam
2001
Biology and biochemistry of papillomaviruses
1984
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Pan-European Sarcoma Trials: Moving Forward in a Climate of Increasing Economic and Regulatory Pressure
2007
Screening with urinary dipsticks for reducing morbidity and mortality
2015
Childhood and adolescent cancer statistics, 2014
2014 Standout
Discarding Logic
2009
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Presence of Human Papillomavirus in Genital Tumors.
1984 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Role of Genetic Susceptibility in Development of Treatment-Related Adverse Outcomes in Cancer Survivors
2011
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Adult-Type Soft Tissue Sarcomas in Pediatric-Age Patients: Experience at the Istituto Nazionale Tumori in Milan
2005
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2003
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
2013
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.
1984 StandoutNobel
Hyperthermia for the treatment of patients with malignant germ cell tumors
1998
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation
1989
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Presence of Human Papillomavirus in Genital Tumors
1984 StandoutNobel
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
1985 StandoutNatureNobel
Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials
1997
Works of J. Treuner being referenced
Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells.
1989
Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donors
1989
Prospective longitudinal evaluation of doxorubicin‐induced cardiomyopathy in sarcoma patients: A report of the late effects surveillance system (LESS)
2005
The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas
2005
Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: Discussion on the role of adjuvant therapies
2005
Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark
1994
Regionale Hyperthermie mit systemischer Chemotherapie bei Kindern und Jugendlichen: Durchführbarkeit und klinische Verläufe bei 34 intensiv vorbehandelten Patienten mit prognostisch ungünstigen Tumorerkrankungen
1993
Soft tissue sarcomas in infants younger than 1 year of age: A report of the German soft tissue sarcoma study group (CWS‐81)
1989
Summary of the International Symposium on Childhood Non-Rhabdomyosarcoma Soft-Tissue Sarcomas, Padua, Italy, February 10–12, 1994
1996
Neuroblastoma mass screening: The arguments for and against
1995
Neuroblastoma Screening at One Year of Age
2002
European Intergroup Studies (MMT4-89 and MMT4-91) on Childhood Metastatic Rhabdomyosarcoma: Final Results and Analysis of Prognostic Factors
2004
Synovial Sarcoma of Childhood and Adolescence: A Multicenter, Multivariate Analysis of Outcome
2003
Kinetics of restoration of interferon production after bone marrow transplantation in man.
1987
Comparison of human fibroblast and leukocyte interferon in the treatment of severe laryngeal papillomatosis in children
1981
Cooperative Trial CWS-91 for Localized Soft Tissue Sarcoma in Children, Adolescents, and Young Adults
2009
Treatment of Orbital Rhabdomyosarcoma: Survival and Late Effects of Treatment—Results of an International Workshop
2001
[Hepatocellular carcinoma following oxymetholone treatment].
1980
Neuroblastoma Screening
1991